Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers
JNCI: Journal of the National Cancer Institute · 01.11.2024 · 116 (11) · 1753-1760
DOI: 10.1093/jnci/djae151 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 27.06.2024. Verfasst von Steven A Narod und 20 weiteren Autor:innen. Beteiligte Einrichtung: Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Ovariectomy, Ovarian Neoplasms, Mutation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canada Research Chair, CIHR, Canadian Cancer Society Research Institute.
Abstract (Originalsprache)
Background
To estimate the incidence of primary peritoneal cancer after preventive bilateral oophorectomy in women with a BRCA1 or BRCA2 mutation.
Methods
A total of 6310 women with a BRCA1 or BRCA2 mutation who underwent a preventive bilateral oophorectomy were followed for a mean of 7.8 years from oophorectomy. The 20-year cumulative incidence of peritoneal cancer post-oophorectomy was estimated using the Kaplan-Meier method. A left-truncated Cox proportional hazards analysis was used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) associated with the age at oophorectomy, year of oophorectomy, and family history of ovarian cancer as well as hormonal and reproductive risk factors.
Results
Fifty-five women developed primary peritoneal cancer (n = 45 in BRCA1, 8 in BRCA2, and 2 in women with a mutation in both genes). Their mean age at oophorectomy was 48.9 years. The annual risk of peritoneal cancer was 0.14% for women with a BRCA1 mutation and 0.06% for women with a BRCA2 mutation. The 20-year cumulative risk of peritoneal cancer from the date of oophorectomy was 2.7% for BRCA1 carriers and 0.9% for BRCA2 mutation carriers. There were no peritoneal cancers in BRCA1 carriers who had the operation before age 35 or in BRCA2 carriers who had the operation before age 45.
Conclusions
For BRCA1 mutation carriers, the annual risk of peritoneal cancer for 20 years post-oophorectomy is 0.14% per year. The risk is lower for BRCA2 carriers (0.06% per year).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
- International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
- Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
- Inherited Cancer Research Group, The Norwegian Radium Hospital, Department for Medical Genetics; and Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital; Oslo University Hospital, Os…
- Beth Israel Deaconess Medical Center, Boston, MA, USA.
ORCID-Profile: Steven A Narod, William D Foulkes, Joanne Kotsopoulos
Förderung
- Canada Research Chair
- CIHR
- Canadian Cancer Society Research Institute
- Peter Gilgan Centre for Women's Cancers at Women's College Hospital
- Canadian Cancer Society
- Canadian Institutes of Health Research
- Peter Gilgan Centre for Women’s Cancers at Women’s College Hospital
Zitieren
APA
Narod, S. A., Gronwald, J., Karlan, B., Moller, P., Huzarski, T., Tung, N., Aeilts, A., Eisen, A., Armel, S. R., Singer, C. F., Foulkes, W. D., Neuhausen, S. L., Olopade, O., Pal, T., Fruscio, R., Metcalfe, K., Raj, R., Jacobson, M., Sun, P., …, & Kotsopoulos, J. (2024). Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers. JNCI: Journal of the National Cancer Institute, 116(11), 1753-1760. https://doi.org/10.1093/jnci/djae151
Vancouver
Narod SA, Gronwald J, Karlan B, Moller P, Huzarski T, Tung N, et al. Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers. JNCI: Journal of the National Cancer Institute. 2024;116(11):1753-1760. doi:10.1093/jnci/djae151
BibTeX
@article{Narod2024,
author = {Narod, Steven A and Gronwald, Jacek and Karlan, Beth and Moller, Pal and Huzarski, Tomasz and Tung, Nadine and Aeilts, Amber and Eisen, Andrea and Armel, Susan Randall and Singer, Christian F and Foulkes, William D and Neuhausen, Susan L and Olopade, Olufunmilayo and Pal, Tuya and Fruscio, Robert and Metcalfe, Kelly and Raj, Rebecca and Jacobson, Michelle and Sun, Ping and Lubinski, Jan and Kotsopoulos, Joanne},
title = {Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
volume = {116},
number = {11},
pages = {1753--1760},
doi = {10.1093/jnci/djae151}
}
EUVIMED